Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue factor pathway inhibitor.

M Camici1, A Sagripanti

  • 1Department of Internal Medicine, Pisa University, Italy.

Minerva Medica
|July 1, 1999
PubMed
Summary
This summary is machine-generated.

Tissue Factor (TF) initiates blood coagulation and is implicated in thrombosis. This study discusses the role of Tissue Factor Pathway Inhibitor (TFPI) as a natural inhibitor of TF and its therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ocular involvement in monkeypox: Description of an unusual presentation during the current outbreak.

The Journal of infection·2022
Same author

A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.

The international journal of biochemistry & cell biology·2015
Same author

The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.

Biochemical pharmacology·2015
Same author

Partial purification and characterization of a proteolytic activity of alfalfa juice.

Journal of agricultural and food chemistry·2009
Same author

The phosphotransferase activity of cytosolic 5'-nucleotidase; a purine analog phosphorylating enzyme.

The international journal of biochemistry & cell biology·2009
Same journal

How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

Minerva medica·2026
Same journal

Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

Minerva medica·2026
Same journal

Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

Minerva medica·2026
Same journal

Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

Minerva medica·2026
Same journal

Iron deficiency and risk of acute kidney injury after TAVI: a machine learning analysis.

Minerva medica·2026
Same journal

Therapeutic adherence and health literacy: a perfect match in dyslipidemic patients.

Minerva medica·2026
See all related articles

Area of Science:

  • Biochemistry
  • Hematology
  • Cell Biology

Background:

  • Tissue Factor (TF) is crucial for initiating blood coagulation.
  • TF's role in venous and arterial thrombosis is increasingly recognized.
  • TF activates coagulation factor IX, contributing to coagulation cascade.

Purpose of the Study:

  • To discuss the physiological role of Tissue Factor Pathway Inhibitor (TFPI).
  • To elucidate the mechanism of action of TFPI.
  • To explore the pharmacological potential of TFPI in managing TF-mediated disorders.

Main Methods:

  • Literature review on TF and TFPI.
  • Analysis of TFPI's interaction with the TF/FVIIa complex.
  • Discussion of TFPI's inhibitory functions.

Related Experiment Videos

Main Results:

  • TFPI directly inhibits the TF/FVIIa complex, acting as a natural anticoagulant.
  • Aberrant TF expression is linked to various intravascular coagulation disorders.
  • TFPI's mechanism involves regulating TF-initiated coagulation.

Conclusions:

  • TFPI is a key regulator of the extrinsic coagulation pathway.
  • Understanding TFPI's function is vital for developing anticoagulant therapies.
  • TFPI holds significant pharmacological potential for treating thrombotic diseases.